These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
409 related items for PubMed ID: 28206770
1. Controlling the Release of Indomethacin from Glass Solutions Layered with a Rate Controlling Membrane Using Fluid-Bed Processing. Part 1: Surface and Cross-Sectional Chemical Analysis. Dereymaker A, Scurr DJ, Steer ED, Roberts CJ, Van den Mooter G. Mol Pharm; 2017 Apr 03; 14(4):959-973. PubMed ID: 28206770 [Abstract] [Full Text] [Related]
2. Controlling the Release of Indomethacin from Glass Solutions Layered with a Rate Controlling Membrane Using Fluid-Bed Processing. Part 2: The Influence of Formulation Parameters on Drug Release. Dereymaker A, Pelgrims J, Engelen F, Adriaensens P, Van den Mooter G. Mol Pharm; 2017 Apr 03; 14(4):974-983. PubMed ID: 28207272 [Abstract] [Full Text] [Related]
3. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Fini A, Cavallari C, Ospitali F. Eur J Pharm Biopharm; 2008 Sep 03; 70(1):409-20. PubMed ID: 18621516 [Abstract] [Full Text] [Related]
4. Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads. Fan C, Pai-Thakur R, Phuapradit W, Zhang L, Tian H, Malick W, Shah N, Kislalioglu MS. Eur J Pharm Sci; 2009 Apr 11; 37(1):1-10. PubMed ID: 19027852 [Abstract] [Full Text] [Related]
5. Investigating the Potential of Ethyl Cellulose and a Porosity-Increasing Agent as a Carrier System for the Formulation of Amorphous Solid Dispersions. Everaerts M, Cools L, Adriaensens P, Reekmans G, Baatsen P, Van den Mooter G. Mol Pharm; 2022 Aug 01; 19(8):2712-2724. PubMed ID: 35476407 [Abstract] [Full Text] [Related]
6. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate. Huang BB, Liu DX, Liu K, Wu G. Molecules; 2019 Nov 26; 24(23):. PubMed ID: 31779169 [Abstract] [Full Text] [Related]
7. The peculiar behavior of the glass transition temperature of amorphous drug-polymer films coated on inert sugar spheres. Dereymaker A, Van Den Mooter G. J Pharm Sci; 2015 May 26; 104(5):1759-66. PubMed ID: 25702912 [Abstract] [Full Text] [Related]
8. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions. Nisar-ur-Rahman, K H Y, Jia Woei W, Khan NA. Pak J Pharm Sci; 2005 Apr 26; 18(2):19-23. PubMed ID: 16431393 [Abstract] [Full Text] [Related]
9. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone. Meeus J, Chen X, Scurr DJ, Ciarnelli V, Amssoms K, Roberts CJ, Davies MC, van Den Mooter G. J Pharm Sci; 2012 Sep 26; 101(9):3473-85. PubMed ID: 22447580 [Abstract] [Full Text] [Related]
10. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets. Terebesi I, Bodmeier R. Eur J Pharm Biopharm; 2010 May 26; 75(1):63-70. PubMed ID: 20079833 [Abstract] [Full Text] [Related]
11. Osmotic pellet system comprising osmotic core and in-process amorphized drug in polymer-surfactant layer for controlled delivery of poorly water-soluble drug. Saindane N, Vavia P. J Pharm Sci; 2012 Sep 26; 101(9):3169-79. PubMed ID: 22418998 [Abstract] [Full Text] [Related]
12. Characterization of the film formation of the dry coating process. Kablitz CD, Urbanetz NA. Eur J Pharm Biopharm; 2007 Sep 26; 67(2):449-57. PubMed ID: 17451928 [Abstract] [Full Text] [Related]
13. Effects of polyvinylpyrrolidone both as a binder and pore-former on the release of sparingly water-soluble topiramate from ethylcellulose coated pellets. Yang M, Xie S, Li Q, Wang Y, Chang X, Shan L, Sun L, Huang X, Gao C. Int J Pharm; 2014 Apr 25; 465(1-2):187-96. PubMed ID: 24530810 [Abstract] [Full Text] [Related]
14. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers. Zhu Y, Shah NH, Malick AW, Infeld MH, McGinity JW. Drug Dev Ind Pharm; 2006 Jun 25; 32(5):569-83. PubMed ID: 16720412 [Abstract] [Full Text] [Related]
15. In situ amorphisation of indomethacin with Eudragit® E during dissolution. Priemel PA, Laitinen R, Grohganz H, Rades T, Strachan CJ. Eur J Pharm Biopharm; 2013 Nov 25; 85(3 Pt B):1259-65. PubMed ID: 24056054 [Abstract] [Full Text] [Related]
16. Influence of copolymer composition on the phase behavior of solid dispersions. Prudic A, Kleetz T, Korf M, Ji Y, Sadowski G. Mol Pharm; 2014 Nov 03; 11(11):4189-98. PubMed ID: 25295846 [Abstract] [Full Text] [Related]
17. Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacin. Doreth M, Löbmann K, Priemel P, Grohganz H, Taylor R, Holm R, Lopez de Diego H, Rades T. Eur J Pharm Biopharm; 2018 Jan 03; 122():62-69. PubMed ID: 28986296 [Abstract] [Full Text] [Related]
18. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology. Nandy BC, Mazumder B. Curr Drug Deliv; 2014 Jan 03; 11(1):72-86. PubMed ID: 24783236 [Abstract] [Full Text] [Related]
19. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. Forster A, Hempenstall J, Rades T. J Pharm Pharmacol; 2001 Mar 03; 53(3):303-15. PubMed ID: 11291745 [Abstract] [Full Text] [Related]
20. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil. Wlodarski K, Sawicki W, Haber K, Knapik J, Wojnarowska Z, Paluch M, Lepek P, Hawelek L, Tajber L. Eur J Pharm Biopharm; 2015 Aug 03; 94():106-15. PubMed ID: 25998701 [Abstract] [Full Text] [Related] Page: [Next] [New Search]